PepperLime Health Acquisition Corporation announces separate trading of its Class A common shares and redeemable warrants effective December 9, 2021

PepperLime Health

PepperLime Health

PepperLime Health

SAN FRANCISCO, December 06, 2021 (GLOBE NEWSWIRE) – PepperLime Health Acquisition Corporation (Nasdaq: PEPLU) (the “Company”) today announced that, effective December 9, 2021, holders of units sold under the initial public offering of the Company of 15,000,000 units completed on October 19, 2020, and a subsequent issue of 2,000,000 additional units completed on October 29, 2021 following the partial exercise by the underwriters of their option to over-allotment as part of the initial public offering, may choose to trade separately the Class A common shares and the redeemable warrants included in the units. These non-segregated units will continue to trade on the Nasdaq Stock Market LLC (“Nasdaq”) under the symbol “PEPLU”, and the Class A common shares and redeemable warrants which are segregated will be traded on the Nasdaq under the “PEPL” symbols. and “PEPLW”, respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will be traded. Unitholders should instruct their brokers to contact Continental Stock Transfer & Trust Company, the transfer agent of the Company, in order to separate the units into Class A common shares and redeemable warrants.

The Company is a blank check company incorporated for the purpose of effecting a merger, a capital stock exchange, an acquisition of assets, a purchase of shares, a reorganization or a similar business combination with one or more companies. .

The units were initially offered by the Company as part of a subscribed offer. Oppenheimer & Co. Inc. acted as the sole accounting manager of the offering. The offer was made only by means of a prospectus. Copies of the prospectus can be obtained from: Oppenheimer & Co. Inc., Attn: Syndicate Prospectus Department, 85 Broad Street, 26th Floor, New York, New York 10004, telephone: (212) 667-8055 or e-mail: EquityProspectus @ opco .com.

A securities registration statement came into effect on October 14, 2020 in accordance with section 8 (a) of the Securities Act of 1933, as amended. This press release does not constitute an offer to sell or the solicitation of an offer to buy, and there will be no sale of such securities in any state or jurisdiction in which such an offer, solicitation or sale would be illegal. prior to registration or qualification under the securities laws of any such state or jurisdiction.

Forward-looking statements
This press release may include “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as “anticipate”, “believe”, “estimate”, “expect”, “intend” and similar expressions, in relation to us or our management team, identify forward-looking statements. These forward-looking statements are based on the beliefs of the management, as well as on the assumptions made by the management of the Company and on the information currently available to the latter. Actual results could differ materially from those contemplated by forward-looking statements due to certain factors detailed in documents filed by the Company with the SEC. All subsequent written or oral forward-looking statements attributable to us or to persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set out in the Risk Factors section of the Company’s registration statement and prospectus relating to the initial public offering of the Company. Company filed with the SEC. The Company assumes no obligation to update these statements for revisions or changes after the date of this posting, except as required by law.

Investor contact:
PepperLime Health Acquisition Corporation
Ramzi haidamus
(415) 263-9939

Related images

Image 1: PepperLime Health

PepperLime Health Logo

This content was published through the press release distribution service on


Source link

Comments are closed.